Two decades ago, I performed India’s first transcatheter aortic valve replacement, at a time when the very idea of changing a heart valve through a small tube, without opening the chest, still struck many as improbable. That idea is now routine for the aortic valve. Its neighbour, the mitral valve, has proved a far harder challenge, and for years it resisted the same approach entirely. That is changing at last, and the change is worth understanding, because it will shape the options open to a great many patients in the years ahead. This is an account of transcatheter mitral valve replacement, known as TMVR, of where it stands today and of where it is carrying us.
What Is TMVR, and How Does It Differ From the Mitral Clip?
Transcatheter Mitral Valve Replacement (TMVR) is precisely what its name implies: replacing a failing mitral valve with an advanced artificial one, delivered entirely through a catheter rather than open surgery. It is vital to separate this procedure clearly from the mitral clip, as the two are frequently confused.
The clip, medically termed transcatheter edge-to-edge repair, does not actually replace anything. Instead, it mends the patient’s native valve by drawing its leaking edges back together to minimise the backflow. TMVR, however, achieves a far more complete outcome. It anchors an entirely new, fully functioning valve right inside the old one, completely abolishing the leak rather than simply reducing it. For patients whose valves are too structurally damaged or whose leaks are too severe for a clip to manage, this distinction changes everything.
Why the Mitral Valve Has Been So Much Harder to Replace Than the Aortic
Patients frequently ask me a very logical question: If we can replace the aortic valve so seamlessly, why has the mitral valve taken so much longer to master? The answer comes down to anatomy, and the engineering reality is genuinely fascinating. The aortic valve is a small, predictable, circular opening, often hardened with calcium deposits that provide a firm, rigid rim for a new valve to grip onto. The mitral valve is its opposite in almost every way. Its opening is large, dynamic, and shaped less like a perfect circle and more like a saddle, or the letter D. Worse, it shifts its shape dramatically with every single heartbeat, usually offering no calcium to anchor against. Furthermore, it sits precariously close to the main channel through which blood exits the heart; an artificial valve placed without absolute precision can crowd that channel, a severe complication we take immense pains to avoid.
In plain terms, replacing the mitral valve is among the most structurally demanding tasks in all of cardiology, which is precisely why the global field has required two decades of deliberate innovation to approach it with absolute confidence.
Where TMVR Stands Today
Here I must be candid, because candour is exactly what my patients deserve. The honest picture of modern heart care is one of real, yet measured progress.
Right now, the most established use of this technique is actually in treating worn-out previous surgeries rather than native, untouched valves. When a surgical valve implanted years ago begins to fail, a surgical repair ring works loose, or a native valve becomes so heavily caked in calcium that it can no longer function, we can now routinely seat a transcatheter valve directly inside that existing structure. These procedures, known clinically as valve-in-valve, valve-in-ring, and valve-in-calcium, spare frail patients from undergoing a dangerous second open-heart operation, and they work beautifully.
Meanwhile, the ultimate prize, a purpose-built replacement valve for an ordinary, leaking mitral valve, reached a historic milestone just last year in 2025. The first dedicated TMVR device was officially approved in the United States for a specific, high-risk group of patients whose calcified valves could not be repaired with a clip. It is a beginning, and a profoundly important one.
The Devices and Trials Shaping What Comes Next
Several purpose-built mitral valves are now moving through careful clinical trials, and following their progress shows clearly where the field is heading. The device approved in 2025 is ingeniously held in place, tethered to the wall of the heart so that it stays steady within that shifting, saddle-shaped opening. Others are being tested in large international studies, one comparing the new valve directly against the mitral clip, another against conventional surgery. Just as important is a change in how these valves are delivered. The earliest were placed through a small incision at the tip of the heart. The newest are guided all the way from a vein in the leg, crossing into the heart through its own inner wall, with no incision at all, along the same elegant route we now use for so much structural work. Each advance lowers the toll on the patient and widens the group who can be helped.
Who TMVR Could Help the Most
The real promise of TMVR is that it may reach the patients who at present fall between our existing options. Surgery remains the finest treatment for those fit enough to undergo it. The clip is an excellent answer for many who are not. Yet there is a group in between and beyond: patients whose valve anatomy is unsuitable for a clip, or whose leak is too severe for a clip to control, and those whose earlier valve or repair has since failed. For them, a replacement delivered through a catheter may one day be the answer that neither the surgeon nor the clip could offer. And because a new valve does away with the leak completely, it promises, in the right patient, a more definitive result than a repair can.
The Problems We Are Still Working to Solve
I would not be giving you an honest account if I pretended this were a finished technology. It is not, and its challenges are real. The first is the danger I mentioned, of a new valve crowding the channel through which blood leaves the heart. We now plan every case with detailed CT scans, and in some patients we deliberately split the old leaflet aside to make room, a clever manoeuvre that has made the procedure markedly safer. Anchoring a valve securely in that soft, calcium-free opening remains difficult, as does sealing it perfectly so that no leak persists around its edge. The new valves must also prove that they last and that they resist clotting, which is why these patients require careful blood-thinning afterwards. Above all, success turns on selecting exactly the right patient, a matter of experience and meticulous imaging as much as of the device itself. This is careful, exacting work, and it belongs in experienced hands.
What This Means for You Today
So where does all of this leave a patient with a leaking mitral valve right now? For most, the established treatments remain the right ones: watchful monitoring for a mild leak, medicines and rhythm control for the functional kind, surgical repair for those fit to have it, and the clip for many who are not. TMVR is not yet a routine option for the ordinary patient, and I would be misleading you to suggest that it were. But for a growing set of difficult cases, above all failed previous valves and heavily calcified ones, it is already changing what is possible, and the direction of travel is unmistakable. Year upon year, the mitral valve is yielding to the same gentle, catheter-based approach that reached the aortic valve before it. The patient who is told today that nothing further can be done may, before very long, be told something different.
My advice, then, is this. If you or someone you love has a complex mitral valve problem, a valve that has failed after earlier surgery, or a leak for which you have been told there is no good option, do not accept that as the final word before seeing a dedicated structural heart team. What was impossible five years ago is becoming possible today, and what is investigational today may well be routine tomorrow. The surest way to learn your options is to be assessed by people who work at this frontier, with the imaging and the experience to tell you honestly what can, and what cannot yet, be done for you.
Dil Se,
Dr. Praveen Chandra
